DEPLOYDatabase

Deployment

hinotori at Hiroshima University Hospital

Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture). Approved in Japan (2020), Singapore (2023), Malaysia (2024), Vietnam (2026), and CE-marked under MDR (July 2026). Authorized for urology, general surgery, gynecology, and thoracic surgery. Approximately 20,000 procedures performed globally.

hinotori by Medicaroid · Catalog entry · 1 source · not yet field-verified · Surgical robots

Track hinotori at Hiroshima University Hospital

Recent coverage

See all coverage →

The hinotori was introduced at Hiroshima University Hospital in January 2022, performing robot-assisted radical prostatectomy and other urologic procedures.

Exposure

Customer segment
healthcare
Scale tier
commercial 10 99

Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Safety record

No incidents on record for hinotori at Hiroshima University Hospital.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 1 source · not yet field-verifiedhow tiers work →
Last updated
2026-08-21
Model
hinotori
Company
Medicaroid
Location
Hiroshima University Hospital
Operator
Medicaroid
Status
operational
Scale at site
11 to 100 units
Site environment
indoor
Location precision
city centroid
First seen
2022-01-01
ID
98ae1959-be9a-4240-8f7b-38a86415b345

Timeline

  1. Jan 2022
    First recorded
    hinotori first documented operating at Hiroshima University Hospital.
  2. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Free to use on your site, with a link back to DEPLOY.

hinotori operates in Hiroshima University Hospital. Explore the full verified map:

Sources (1)

  1. https://www.sciencedirect.com/science/article/pii/S2214388224000961
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-21

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for hinotori at Hiroshima University Hospital.

Common questions

What is the hinotori deployment at Hiroshima University Hospital?
hinotori, built by Medicaroid, is recorded as a deployment at Hiroshima University Hospital on the DEPLOY registry. Medicaroid operates the deployment directly.
Who operates hinotori at Hiroshima University Hospital?
Medicaroid, the manufacturer of hinotori, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the hinotori deployment at Hiroshima University Hospital go live?
The deployment is recorded as starting January 1, 2022 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the hinotori deployment at Hiroshima University Hospital?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces